Blood Sampling for Neurochemical and Genetic Testing

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

1999-10-31

Study Completion Date

2004-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study involves sampling blood from both normal volunteers and patients with diseases known or suspected to involve body chemicals called catecholamines. The blood will be used to establish normal values for plasma levels of catecholamines and related neurochemicals; to test for abnormal neurochemical patterns in patients; and to establish a "bank" of DNA from normal volunteers and from patients to be used in future studies about possible alterations of catecholamine-related genes.

Study participants will report to NIH after fasting overnight except for water or noncaloric, noncaffeinated beverages. They must not have taken Tylenol for at least 5 days. Blood will then be drawn. DNA will be extracted and stored in the freezer for future studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Autonomic Failure Patients for RNA Blood Sampling

NCT00742586

Pure Autonomic Failure Multiple System Atrophy Parkinson's Plus Syndromes

COMPLETED

Whole Blood Specimen Collection From Healthy Subjects

NCT02797743

Healthy Volunteers

UNKNOWN

Cause and Pathogenesis of Neurometabolic Disorders

NCT00016562

Neurodegenerative Disease

COMPLETED

Characterization of Phenotypic and Genotypic Regressors for Imaging

NCT01148381

Healthy Volunteers Substance Use Disorders

COMPLETED

Effect of Functional Genetic Polymorphisms on Brain Morphology and Function

NCT01035723

Drug Abuse

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project is to allow blood sampling from normal volunteers and patients with dysautonomia, pheochromocytoma, hypertension, or neurogenetic diseases involving catecholaminergic systems. The blood is used to establish normal values for plasma levels of catechols and related neurochemicals; test for abnormal neurochemical patterns in patients; and establish a "bank" of DNA samples from normal volunteers and from patients, to be used in future studies about mutations or polymorphisms of catecholamine-related genes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autonomic Nervous System Disease Healthy Hypertension Pheochromocytoma

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The subjects are healthy normal volunteers or patients with dysautonomia, pheochromocytoma, hypertension, or neurogenetic diseases involving catecholaminergic systems. Children of any age above 4 years may participate. In the case of minors, consent is obtained from an adult who is legally responsible for the subject.

Exclusion Criteria

Subjects in whom anatomic or technical factors preclude insertion of an arm intravenous (i.v.) catheter are excluded. Normal volunteers taking any prescribed medication are excluded. Normal volunteers who smoke cigarettes or consume alcohol daily are excluded.

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes